Unlike existing Covid-19 tests ours identifies infectious people before symptoms occur, at home in seconds. Crucial to stop spread by unknowing carriers. Low cost, award-winning, peer-reviewed, patent-pending, smartphone-based. Gov funding allocated.
Sign up now to gain full access to pitches and investor profiles
You have passed the test and you may continue your with your investment.